Details for this torrent 

The Pfizer Documents - July 2022 Update
Type:
Other > Other
Files:
725
Size:
11.71 GiB (12569493349 Bytes)
Uploaded:
2022-07-05 23:39:56 GMT
By:
Anonymous
Seeders:
0
Leechers:
2
Comments
0  

Info Hash:
098BDF41DDB0E77FC3E6A05DAE59DC709F272ABE




 Get this torrent  PLAY/STREAM TORRENT  ANONYMOUS DOWNLOAD
(Problems with magnets links are fixed by upgrading your torrent client!)
The Pfizer Documents - July 2022 Update

 Get this torrent  PLAY/STREAM TORRENT  ANONYMOUS DOWNLOAD
pd-production-011822/CRFs-for-site-1096.pdf11.28 MiB
.pad/758343740.57 KiB
pd-production-013122/CRFs-for-site-1128.pdf13.55 MiB
.pad/470569459.54 KiB
pd-production-030122/125742_S1_M1_356h.pdf714.46 KiB
.pad/13655451.3 MiB
pd-production-030122/125742_S1_M1_3674.pdf5.12 MiB
.pad/925235903.55 KiB
pd-production-030122/125742_S1_M1_cover.pdf1.32 MiB
.pad/717662700.84 KiB
pd-production-030122/125742_S1_M1_debarment.pdf656.42 KiB
.pad/14249821.36 MiB
pd-production-030122/125742_S1_M1_exclusivity-claim.pdf616.11 KiB
.pad/14662591.4 MiB
pd-production-030122/125742_S1_M1_fast-track-designation.pdf649.42 KiB
.pad/14321491.37 MiB
pd-production-030122/125742_S1_M1_financial-cert-3454.pdf3.44 MiB
.pad/590670576.83 KiB
pd-production-030122/125742_S1_M1_financial-cert-bias.pdf695.81 KiB
.pad/13846421.32 MiB
pd-production-030122/125742_S1_M1_ipsp-agreed-letter.pdf657.84 KiB
.pad/14235241.36 MiB
pd-production-030122/125742_S1_M1_priority-review-request.pdf1.59 MiB
.pad/432507422.37 KiB
pd-production-030122/125742_S1_M1_trans-of-oblig.pdf717.14 KiB
.pad/13628041.3 MiB
pd-production-030122/125742_S1_M1_us-agent-authorization.pdf1.03 MiB
.pad/1012417988.69 KiB
pd-production-030122/125742_S1_M1_userfee.pdf627.8 KiB
.pad/14542851.39 MiB
pd-production-030122/125742_S1_M1_waiver-req-designated-suffix.pdf2.74 MiB
.pad/13257611.26 MiB
pd-production-030122/125742_S1_M2_22_introduction.pdf670.17 KiB
.pad/14109001.35 MiB
pd-production-030122/125742_S1_M2_24_nonclinical-overview.pdf1.61 MiB
.pad/408351398.78 KiB
pd-production-030122/125742_S1_M2_26_pharmkin-tabulated-summary.pdf1.34 MiB
.pad/688988672.84 KiB
pd-production-030122/125742_S1_M2_26_pharmkin-written-summary.pdf1.43 MiB
.pad/600163586.1 KiB
pd-production-030122/125742_S1_M2_27_literature-references.pdf1.75 MiB
.pad/264301258.11 KiB
pd-production-030122/125742_S1_M2_27_synopses-indiv-studies.pdf1.75 MiB
.pad/263583257.41 KiB
pd-production-030122/125742_S1_M4_4223_185350.pdf1.4 MiB
.pad/629773615.01 KiB
pd-production-030122/125742_S1_M4_4223_R-20-0072.pdf5.21 MiB
.pad/823457804.16 KiB
pd-production-030122/125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf889.15 KiB
.pad/11866621.13 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf1.26 MiB
.pad/778153759.92 KiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf2.04 MiB
.pad/20550351.96 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf2.39 MiB
.pad/16912251.61 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-errata.pdf2.27 MiB
.pad/18188481.73 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf15.7 MiB
.pad/312541305.22 KiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf1.81 MiB
.pad/196859192.25 KiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf4.78 MiB
.pad/12760061.22 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf12.02 MiB
.pad/20751061.98 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf2.29 MiB
.pad/17944261.71 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf31.31 MiB
.pad/727002709.96 KiB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf13 MiB
.pad/10511781 MiB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf36.94 MiB
.pad/11143701.06 MiB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851018.pdf2.25 MiB
.pad/18323521.75 MiB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851116.pdf1.19 MiB
.pad/845807825.98 KiB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851129.pdf1.94 MiB
.pad/6625464.7 KiB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851216.pdf1.22 MiB
.pad/814548795.46 KiB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851246.pdf1.14 MiB
.pad/898888877.82 KiB
pd-production-030122/125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf602.23 KiB
.pad/14804711.41 MiB
pd-production-030122/125742_S1_M5_c4591001-A-adrg.pdf1.54 MiB
.pad/484750473.39 KiB
pd-production-030122/125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf627.05 KiB
.pad/14550551.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf634.25 KiB
.pad/14476771.38 MiB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf620.2 KiB
.pad/14620661.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-comorbidity-categories.pdf636.9 KiB
.pad/14449711.38 MiB
pd-production-030122/125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf606.89 KiB
.pad/14756981.41 MiB
pd-production-030122/125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf846.03 KiB
.pad/12308151.17 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf629.08 KiB
.pad/14529691.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf670.23 KiB
.pad/14108321.35 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf631.62 KiB
.pad/14503711.38 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-chf.pdf628.18 KiB
.pad/14538991.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-dementia.pdf625.82 KiB
.pad/14563101.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf625.67 KiB
.pad/14564671.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf626.79 KiB
.pad/14553231.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf625.58 KiB
.pad/14565591.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-leukemia.pdf631.44 KiB
.pad/14505541.38 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf640.12 KiB
.pad/14416721.37 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf635.64 KiB
.pad/14462521.38 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mi.pdf624.25 KiB
.pad/14579241.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf628.36 KiB
.pad/14537111.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf625.68 KiB
.pad/14564581.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf624.81 KiB
.pad/14573471.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf631.6 KiB
.pad/14503941.38 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf629.63 KiB
.pad/14524101.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-renal.pdf628.94 KiB
.pad/14531151.39 MiB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf629.4 KiB
.pad/14526481.39 MiB
pd-production-030122/125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf2.22 MiB
.pad/18688991.78 MiB
pd-production-030122/125742_S1_M5_c4591001-T-S-roadmap.pdf702.77 KiB
.pad/13775171.31 MiB
pd-production-030122/125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf666.79 KiB
.pad/14143561.35 MiB
pd-production-030122/125742_S1_M5_c4591001-T-S-suppl-arg.pdf738.13 KiB
.pad/13413101.28 MiB
pd-production-030122/125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf17.43 MiB
.pad/600698586.62 KiB
pd-production-030122/FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt13.87 KiB
.pad/20829471.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt14.67 KiB
.pad/20821351.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt14.75 KiB
.pad/20820491.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt15.11 KiB
.pad/20816831.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt35.46 KiB
.pad/20608361.97 MiB
pd-production-030122/FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt17.94 KiB
.pad/20787831.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt81.06 KiB
.pad/20141491.92 MiB
pd-production-030122/FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt19.55 KiB
.pad/20771311.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt19.46 KiB
.pad/20772261.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt12.27 KiB
.pad/20845921.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt71.56 KiB
.pad/20238711.93 MiB
pd-production-030122/FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt192.86 KiB
.pad/18996681.81 MiB
pd-production-030122/FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt27.11 KiB
.pad/20693931.97 MiB
pd-production-030122/FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt32.19 KiB
.pad/20641931.97 MiB
pd-production-030122/FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt155.76 KiB
.pad/19376571.85 MiB
pd-production-030122/FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt11.04 KiB
.pad/20858421.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt48.94 KiB
.pad/20470361.95 MiB
pd-production-030122/FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt24.03 KiB
.pad/20725491.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt74.64 KiB
.pad/20207241.93 MiB
pd-production-030122/FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt74.71 KiB
.pad/20206481.93 MiB
pd-production-030122/FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt29.2 KiB
.pad/20672551.97 MiB
pd-production-030122/FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt75.39 KiB
.pad/20199481.93 MiB
pd-production-030122/FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt197.17 KiB
.pad/18952521.81 MiB
pd-production-030122/FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt43.24 KiB
.pad/20528741.96 MiB
pd-production-030122/FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt44.8 KiB
.pad/20512781.96 MiB
pd-production-030122/FDA-CBER-2021-5683-0023150 to -0023454_125742_S1_M5_c4591001-A-define.xml1.37 MiB
.pad/659438643.98 KiB
pd-production-030122/FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl183.26 KiB
.pad/19094951.82 MiB
pd-production-030122/FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx12.98 KiB
.pad/20838611.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx28.74 KiB
.pad/20677261.97 MiB
pd-production-030122/FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx18.48 KiB
.pad/20782281.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx18.86 KiB
.pad/20778401.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx22.28 KiB
.pad/20743421.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx84.13 KiB
.pad/20110001.92 MiB
pd-production-030122/FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx22.73 KiB
.pad/20738801.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx34.78 KiB
.pad/20615331.97 MiB
pd-production-030122/FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx12.44 KiB
.pad/20844171.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx10.25 KiB
.pad/20866531.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx9.44 KiB
.pad/20874871.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx9.2 KiB
.pad/20877291.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx9.77 KiB
.pad/20871441.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx9.58 KiB
.pad/20873391.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx11.67 KiB
.pad/20851991.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx17.02 KiB
.pad/20797191.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx14.32 KiB
.pad/20824841.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx8.9 KiB
.pad/20880381.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx10.35 KiB
.pad/20865581.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx9.2 KiB
.pad/20877311.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx9.15 KiB
.pad/20877811.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx11.71 KiB
.pad/20851631.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx11.55 KiB
.pad/20853241.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx11.09 KiB
.pad/20857961.99 MiB
pd-production-030122/FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx23.94 KiB
.pad/20726391.98 MiB
pd-production-030122/FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx21.34 KiB
.pad/20753031.98 MiB
pd-production-032422/125742_S1_M1_priority-review-request.pdf2.37 MiB
.pad/17099691.63 MiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdf869.17 KiB
.pad/12071211.15 MiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf27.74 MiB
.pad/273415267.01 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdf7.56 MiB
.pad/463782452.91 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdf677.14 KiB
.pad/14037631.34 MiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdf1.17 MiB
.pad/871933851.5 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-publications.pdf9.76 MiB
.pad/248172242.36 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdf59.43 MiB
.pad/594323580.39 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-randomization.pdf1.51 MiB
.pad/512521500.51 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdf5.4 MiB
.pad/632511617.69 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdf2.31 MiB
.pad/17765061.69 MiB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdf1.2 MiB
.pad/841741822.01 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdf1.28 MiB
.pad/759015741.23 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf27.77 MiB
.pad/245429239.68 KiB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdf1.18 MiB
.pad/860055839.9 KiB
pd-production-040122/reissue_5.3.6 postmarketing experience.pdf957.62 KiB
.pad/11165491.06 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf7.08 MiB
.pad/962962940.39 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf7.44 MiB
.pad/582248568.6 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf2.33 MiB
.pad/17463651.67 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf1.99 MiB
.pad/1154111.27 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf2.01 MiB
.pad/20870231.99 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf1.09 MiB
.pad/950478928.2 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf634.42 KiB
.pad/14475051.38 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf6.28 MiB
.pad/18041761.72 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf91.06 MiB
.pad/987283964.14 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf1.21 MiB
.pad/832387812.88 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf2.56 MiB
.pad/15092601.44 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf1.47 MiB
.pad/555434542.42 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf10.46 MiB
.pad/16096871.54 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf41.63 MiB
.pad/388238379.14 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf9.1 MiB
.pad/940784918.73 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sap.pdf2.91 MiB
.pad/11476861.09 MiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf1.97 MiB
.pad/2746226.82 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf1.52 MiB
.pad/508004496.1 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf3.71 MiB
.pad/308694301.46 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01_10010.pdf1.46 MiB
.pad/562720549.53 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01_10075.pdf1.59 MiB
.pad/429379419.32 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20116.pdf1.51 MiB
.pad/518792506.63 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20215.pdf1.63 MiB
.pad/391315382.14 KiB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20242.pdf1.66 MiB
.pad/357464349.09 KiB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf64.92 MiB
.pad/11326771.08 MiB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf5.39 MiB
.pad/643776628.69 KiB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf11.95 MiB
.pad/5682855.5 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011093.pdf2.62 MiB
.pad/14428791.38 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011100.pdf2.13 MiB
.pad/19587341.87 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011135.pdf1.42 MiB
.pad/603729589.58 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031038.pdf2.71 MiB
.pad/13479391.29 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031065.pdf2.66 MiB
.pad/14033551.34 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031111.pdf1.71 MiB
.pad/303249296.14 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031113.pdf3.22 MiB
.pad/814399795.31 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031149.pdf1.63 MiB
.pad/387110378.04 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031186.pdf2.42 MiB
.pad/16599211.58 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031197.pdf1.48 MiB
.pad/547979535.14 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031207.pdf1.44 MiB
.pad/584327570.63 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051047.pdf1.39 MiB
.pad/635099620.21 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051054.pdf1.88 MiB
.pad/124421121.5 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051069.pdf1.46 MiB
.pad/562980549.79 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051214.pdf1.38 MiB
.pad/653899638.57 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051293.pdf2.41 MiB
.pad/16679041.59 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051347.pdf1.45 MiB
.pad/577797564.25 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051387.pdf1.69 MiB
.pad/327366319.69 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051411.pdf1.35 MiB
.pad/682006666.02 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061020.pdf1.52 MiB
.pad/501069489.33 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061040.pdf3.82 MiB
.pad/193244188.71 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061052.pdf2.12 MiB
.pad/19692971.88 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061094.pdf2.08 MiB
.pad/20082391.92 MiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061098.pdf1.57 MiB
.pad/446062435.61 KiB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061176.pdf2.63 MiB
.pad/14343621.37 MiB
pd-production-050222/125742_S1_M5_bnt162-01-A-adrg.pdf891.07 KiB
.pad/11846991.13 MiB
pd-production-050222/125742_S1_M5_bnt162-01-S-acrf.pdf1.4 MiB
.pad/632736617.91 KiB
pd-production-050222/125742_S1_M5_bnt162-01-S-csdrg.pdf1.2 MiB
.pad/841024821.31 KiB
pd-production-050222/125742_S1_M5_c4591001-S-Supp-acrf.pdf2.89 MiB
.pad/11679101.11 MiB
pd-production-050222/125742_S1_M5_c4591001-S-acrf.pdf2.89 MiB
.pad/11679071.11 MiB
pd-production-050222/125742_S1_M5_c4591001-S-csdrg.pdf1.43 MiB
.pad/601728587.63 KiB
pd-production-050222/FDA-CBER-2021-5683-0058316 to -0058458_125742_S1_M5_c4591001-A-Supp-define.xml691.95 KiB
.pad/13885941.32 MiB
pd-production-050222/FDA-CBER-2021-5683-0058459 to -0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl183.26 KiB
.pad/19094951.82 MiB
pd-production-050222/FDA-CBER-2021-5683-0058479 to -0058594_125742_S1_M5_c4591001-S-define.xml904.18 KiB
.pad/11712721.12 MiB
pd-production-050222/FDA-CBER-2021-5683-0058595 to -0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl183.26 KiB
.pad/19094951.82 MiB
pd-production-050222/FDA-CBER-2021-5683-0058615 to -0058652_125742_S1_M5_c4591001-S-Supp-define.xml299.8 KiB
.pad/17901591.71 MiB
pd-production-050222/FDA-CBER-2021-5683-0058653 to -0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl183.26 KiB
.pad/19094951.82 MiB
pd-production-050222/FDA-CBER-2021-5683-0058676 to -0058794_125742_S1_M5_bnt162-01-A-define.xml828.13 KiB
.pad/12491501.19 MiB
pd-production-050222/FDA-CBER-2021-5683-0058795 to -0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl183.26 KiB
.pad/19094951.82 MiB
pd-production-050222/FDA-CBER-2021-5683-0058829 to -0058954_125742_S1_M5_bnt162-01-S-define.xml985.5 KiB
.pad/10880031.04 MiB
pd-production-050222/FDA-CBER-2021-5683-0058955 to -0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl183.26 KiB
.pad/19094951.82 MiB
pd-production-050222/FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt394.37 MiB
.pad/17138561.63 MiB
pd-production-050222/FDA-CBER-2021-5683-0065774 to -0066700_125742_S1_M5_c4591001-A-D-addv.xpt43.54 MiB
.pad/478144466.94 KiB
pd-production-050222/FDA-CBER-2021-5683-0066701 to -0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt3.85 GiB
.pad/18547681.77 MiB
pd-production-050222/FDA-CBER-2021-5683-0123168 to -0126026_125742_S1_M5_c4591001-A-D-adva.xpt162.85 MiB
.pad/12011041.15 MiB
pd-production-060122/125742_S1_M2_summary-biopharm.pdf1.74 MiB
.pad/274455268.02 KiB
pd-production-060122/125742_S1_M5_5314_shi-sop-10011.pdf2.08 MiB
.pad/20180381.92 MiB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf31.71 MiB
.pad/299998292.97 KiB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-discontinued-patients.pdf2.91 MiB
.pad/11433881.09 MiB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-patient-batches.pdf1.26 MiB
.pad/771179753.1 KiB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations-sensitive.pdf1.51 MiB
.pad/515047502.98 KiB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-patient-batches.pdf1.34 MiB
.pad/692090675.87 KiB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf11.18 MiB
.pad/859029838.9 KiB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-randomization.pdf1.2 MiB
.pad/840900821.19 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071050.pdf3 MiB
.pad/10503981 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071097.pdf2.08 MiB
.pad/20117821.92 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071101.pdf1.48 MiB
.pad/550361537.46 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071117.pdf1.9 MiB
.pad/105781103.3 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071124.pdf1.72 MiB
.pad/297052290.09 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071159.pdf1.29 MiB
.pad/741690724.31 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071192.pdf1.84 MiB
.pad/163943160.1 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071276.pdf1.77 MiB
.pad/245954240.19 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071280.pdf1.91 MiB
.pad/9632394.07 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071306.pdf2.76 MiB
.pad/12993171.24 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071315.pdf1.42 MiB
.pad/609976595.68 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071347.pdf1.45 MiB
.pad/575971562.47 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071441.pdf1.25 MiB
.pad/790028771.51 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071443.pdf1.31 MiB
.pad/721024704.13 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081056.pdf1.21 MiB
.pad/824405805.08 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081152.pdf1.01 MiB
.pad/10335641009.34 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081184.pdf1.18 MiB
.pad/854879834.84 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081337.pdf1.24 MiB
.pad/793893775.29 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081603.pdf1.31 MiB
.pad/718596701.75 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081628.pdf1.19 MiB
.pad/852594832.61 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081667.pdf1.27 MiB
.pad/767836749.84 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091123.pdf1.26 MiB
.pad/778558760.31 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091128.pdf1.62 MiB
.pad/398152388.82 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091135.pdf1.72 MiB
.pad/293428286.55 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091149.pdf1.47 MiB
.pad/552114539.17 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1011-10111029.pdf1.53 MiB
.pad/495274483.67 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1011-10111181.pdf1.19 MiB
.pad/845473825.66 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121097.pdf1.81 MiB
.pad/201198196.48 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121112.pdf1.69 MiB
.pad/325554317.92 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121163.pdf1.56 MiB
.pad/462617451.77 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131084.pdf1.37 MiB
.pad/659116643.67 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131089.pdf1.43 MiB
.pad/594476580.54 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131165.pdf1.3 MiB
.pad/735942718.69 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131176.pdf2.78 MiB
.pad/12764531.22 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131190.pdf2.3 MiB
.pad/17774471.7 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131229.pdf1.15 MiB
.pad/892619871.7 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131255.pdf1.33 MiB
.pad/697841681.49 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131386.pdf1008.3 KiB
.pad/10646561.02 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131517.pdf1.18 MiB
.pad/857540837.44 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131554.pdf2.32 MiB
.pad/17576141.68 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131653.pdf1.23 MiB
.pad/804898786.03 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131656.pdf1.22 MiB
.pad/819876800.66 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131658.pdf1.07 MiB
.pad/977908954.99 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131699.pdf2.34 MiB
.pad/17403431.66 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131718.pdf2.18 MiB
.pad/19048601.82 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131786.pdf3.13 MiB
.pad/911785890.42 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151011.pdf1.35 MiB
.pad/683323667.31 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151035.pdf1.24 MiB
.pad/799039780.31 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151047.pdf1.15 MiB
.pad/893160872.23 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151071.pdf1.23 MiB
.pad/812613793.57 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151089.pdf1.24 MiB
.pad/801861783.07 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151101.pdf1.05 MiB
.pad/995171971.85 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151134.pdf1.47 MiB
.pad/557732544.66 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151225.pdf1.47 MiB
.pad/555658542.63 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151238.pdf2.52 MiB
.pad/15518131.48 MiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1081-10811194 reissue.pdf1.76 MiB
.pad/249009243.17 KiB
pd-production-060122/125742_S1_M5_CRF_c4591001-1128-11281009 reissue.pdf1.88 MiB
.pad/128947125.92 KiB
pd-production-060122/FDA-CBER-2021-5683-0142307 to -0149081_125742_S1_M5_c4591001-A-Supp-D-adcevd.xpt425.98 MiB
.pad/1601615.64 KiB
pd-production-060122/FDA-CBER-2021-5683-0149082 to -0158559_125742_S1_M5_c4591001-S-D-ce.xpt368.08 MiB
.pad/20156001.92 MiB
pd-production-060122/FDA-CBER-2021-5683-0158560 to -0159486_125742_S1_M5_c4591001-S-D-dv.xpt11.43 MiB
.pad/593072579.17 KiB
pd-production-060122/FDA-CBER-2021-5683-0159487 to -0162689_125742_S1_M5_c4591001-S-D-ec.xpt46.56 MiB
.pad/15056481.44 MiB
pd-production-060122/FDA-CBER-2021-5683-0162690 to -0165892_125742_S1_M5_c4591001-S-D-ex.xpt44.73 MiB
.pad/13362561.27 MiB
pd-production-060122/FDA-CBER-2021-5683-0165893 to -0168682_125742_S1_M5_c4591001-S-D-is.xpt29.38 MiB
.pad/647120631.95 KiB
pd-production-060122/FDA-CBER-2021-5683-0168683 to -0169081_125742_S1_M5_c4591001-S-D-suppcm.xpt2.75 MiB
.pad/13139041.25 MiB
pd-production-060122/FDA-CBER-2021-5683-0169082 to -0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt13.7 MiB
.pad/313184305.84 KiB
pd-production-060122/FDA-CBER-2021-5683-0171524 to -0174606_125742_S1_M5_c4591001-S-D-suppds.xpt16.94 MiB
.pad/11126881.06 MiB
pd-production-060122/FDA-CBER-2021-5683-0174607 to -0178318_125742_S1_M5_c4591001-S-D-suppdv.xpt23.37 MiB
.pad/659504644.05 KiB
pd-production-060122/FDA-CBER-2021-5683-0178319 to -0180190_125742_S1_M5_c4591001-S-D-suppho.xpt8.22 MiB
.pad/18711201.78 MiB
pd-production-060122/FDA-CBER-2021-5683-0180191 to -0182980_125742_S1_M5_c4591001-S-D-suppis.xpt7.99 MiB
.pad/1524814.89 KiB
pd-production-060122/FDA-CBER-2021-5683-0182981 to -0187905_125742_S1_M5_c4591001-S-D-suppmh.xpt21.61 MiB
.pad/407232397.69 KiB
pd-production-060122/FDA-CBER-2021-5683-0187906 to -0196048_125742_S1_M5_c4591001-S-D-suppvs.xpt39.15 MiB
.pad/896320875.31 KiB
pd-production-060122/FDA-CBER-2021-5683-0196049 to -0205317_125742_S1_M5_c4591001-S-Supp-D-ce.xpt361.39 MiB
.pad/636912621.98 KiB
pd-production-060122/FDA-CBER-2021-5683-0205318 to -0208520_125742_S1_M5_c4591001-S-Supp-D-ex.xpt44.73 MiB
.pad/13362561.27 MiB
pd-production-060122/FDA-CBER-2021-5683-0208521 to -0216666_125742_S1_M5_c4591001-S-Supp-D-suppvs.xpt39.16 MiB
.pad/881840861.17 KiB
pd-production-060122/STN 125742-0-0 Section 2.5 Clinical Overview reissue.pdf4.72 MiB
.pad/13430981.28 MiB
pd-production-070122/125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf18.85 MiB
.pad/12057971.15 MiB
pd-production-070122/125742_S1_M5_5351_c4591001-fa-interim-sap.pdf3.23 MiB
.pad/809088790.13 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.pdf183.44 MiB
.pad/592102578.22 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-compliance-sensitive.pdf1.2 MiB
.pad/837915818.28 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf4.19 MiB
.pad/18978441.81 MiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-efficacy-response.pdf1.22 MiB
.pad/817399798.24 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-errata.pdf1.8 MiB
.pad/204688199.89 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients-sensitive.pdf2.79 MiB
.pad/12705021.21 MiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients.pdf1.29 MiB
.pad/745371727.9 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf10.87 MiB
.pad/11888891.13 MiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf5.4 MiB
.pad/625173610.52 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-protocol-deviations.pdf1.63 MiB
.pad/384753375.74 KiB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-sap.pdf5.4 MiB
.pad/633915619.06 KiB
pd-production-070122/125742_S2_M1_com195lkz-carton-kzoo.pdf1023.85 KiB
.pad/10487261 MiB
pd-production-070122/125742_S2_M1_com195lpus-carton-puurs.pdf691.06 KiB
.pad/13895091.33 MiB
pd-production-070122/125742_S2_M1_com25ctkz-carton-kzoo.pdf631.94 KiB
.pad/14500491.38 MiB
pd-production-070122/125742_S2_M1_com25ctpus-carton-puurs.pdf671.91 KiB
.pad/14091201.34 MiB
pd-production-070122/125742_S2_M1_comvlabkz-vial-kzoo.pdf863.25 KiB
.pad/12131791.16 MiB
pd-production-070122/125742_S2_M1_comvlabp-vial-puurs.pdf648.34 KiB
.pad/14332481.37 MiB
pd-production-070122/125742_S2_M1_fk-diluent-carton.pdf607.13 KiB
.pad/14754511.41 MiB
pd-production-070122/125742_S2_M1_fk-diluent-stamp.pdf598.24 KiB
.pad/14845521.42 MiB
pd-production-070122/125742_S2_M1_hospira-diluent-carton.pdf987.15 KiB
.pad/10863061.04 MiB
pd-production-070122/125742_S2_M1_hospira-diluent-label.pdf776.28 KiB
.pad/13022411.24 MiB
pd-production-070122/125742_S2_M1_loa-dmf-011321-vials.pdf1019.09 KiB
.pad/10536051 MiB
pd-production-070122/125742_S2_M1_loa-dmf-011793-vials.pdf701.08 KiB
.pad/13792411.32 MiB
pd-production-070122/125742_S2_M1_loa-dmf-011820-vials.pdf616.16 KiB
.pad/14662001.4 MiB
pd-production-070122/125742_S2_M1_loa-dmf-012683-vials.pdf630.9 KiB
.pad/14511091.38 MiB
pd-production-070122/125742_S2_M1_loa-dmf-031786-vials.pdf1.95 MiB
.pad/4858347.44 KiB
pd-production-070122/125742_S2_M1_loa-dmf-10953-stopper.pdf860.66 KiB
.pad/12158391.16 MiB
pd-production-070122/125742_S2_M1_right-of-reference.pdf1.73 MiB
.pad/282076275.46 KiB
pd-production-070122/125742_S2_M5_5354_wi235284-protocol.pdf15.5 MiB
.pad/525081512.77 KiB
pd-production-070122/FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.xpt46.4 MiB
.pad/16766881.6 MiB
pd-production-070122/FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.xpt3.95 GiB
.pad/489504478.03 KiB
pd-production-070122/FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.xpt3.99 MiB
.pad/61446 KiB
pd-production-070122/FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.xpt479.61 KiB
.pad/16060321.53 MiB
pd-production-070122/FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.xpt48.15 MiB
.pad/19356801.85 MiB
pd-production-070122/FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.xpt75.78 KiB
.pad/20195521.93 MiB
pd-production-070122/FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.xpt8.89 MiB
.pad/11588801.11 MiB
pd-production-070122/FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.xpt568.2 KiB
.pad/15153121.45 MiB
pd-production-070122/FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.xpt83.19 MiB
.pad/854544834.52 KiB
pd-production-070122/FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.xpt53.58 MiB
.pad/439744429.44 KiB
pd-production-111721/5.2-listing-of-clinical-sites-and-cvs-pages-1-41.pdf8.01 MiB
.pad/20857901.99 MiB
pd-production-111721/5.2-tabular-listing.pdf1.72 MiB
.pad/293877286.99 KiB
pd-production-111721/5.3.6-postmarketing-experience.pdf983.55 KiB
.pad/10899951.04 MiB
pd-production-111721/BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txt9.11 KiB
.pad/20878281.99 MiB
pd-production-111721/BATES-93_tv.xpt15.55 KiB
.pad/20812321.98 MiB
pd-production-120121/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf12.29 MiB
.pad/17921141.71 MiB
pd-production-120121/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf13.78 MiB
.pad/234376228.88 KiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt8.5 KiB
.pad/20884471.99 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt8.52 KiB
.pad/20884271.99 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt9.11 KiB
.pad/20878281.99 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt4.53 KiB
.pad/20925092 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002376_relrec.xpt566.64 KiB
.pad/15169121.45 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002377_supppr.xpt71.8 KiB
.pad/20236321.93 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002378_ta.xpt8.44 KiB
.pad/20885121.99 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002379_te.xpt3.28 KiB
.pad/20937922 MiB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002380_ti.xpt36.95 KiB
.pad/20593121.96 MiB
pd-production-121321/CRFs-for-site-1055.pdf6.42 MiB
.pad/16601831.58 MiB
pd-production-121321/STN-125742_0_0-Section-2.5-Clinical-Overview.pdf4.2 MiB
.pad/18877611.8 MiB
pd-production-121321/STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf3.15 MiB
.pad/886416865.64 KiB
pd-production-121321/STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf6.5 MiB
.pad/15765551.5 MiB
pd-production-121321/signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf206.58 KiB
.pad/18856191.8 MiB
pd-production-122221/Supplemental-Index-12-22-21.pdf1.94 MiB
.pad/6275261.28 KiB
pd-production-123021/CRFs-for-site-1081.pdf13.2 MiB